Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 26, 2025
For those with schizophrenia, does cannabidiol make cannabis use safer?
Anya K Bershad
Biological Psychiatry
|
August 23, 2023
Psychedelic Microdosing: What Is It Good For?
Anya K Bershad
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
February 10, 2024
Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy
Yasmin Schmid, Anya K Bershad
Biological Psychiatry
|
July 20, 2019
Beyond Bootstraps: Pulling Children Up With Evidence-Based Interventions
Anya K Bershad, David A Ross
Schizophrenia Bulletin
|
June 26, 2023
Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia
Anya K Bershad, Harriet de Wit
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 9, 2019
MDMA enhances pleasantness of affective touch
Harriet de Wit, Anya K Bershad
Biological Psychiatry
|
September 14, 2024
Social Homeostasis and Psychoactive Drugs: What Can We Learn From Opioid and Amphetamine Drug Challenge Studies in Humans?
Anya K Bershad, Harriet de Wit
Journal of Psychopharmacology (Oxford, England)
|
May 29, 2016
Effects of d-amphetamine upon psychosocial stress responses
Emma Childs, Anya K Bershad, Harriet de Wit
Journal of Psychopharmacology (Oxford, England)
|
May 4, 2021
Challenges in translational research: MDMA in the laboratory versus therapeutic settings
Harriet de Wit, Anya K Bershad, Charles Grob
Psychoneuroendocrinology
|
September 1, 2017
Pharmacological challenge studies with acute psychosocial stress
Kathryne Van Hedger, Anya K Bershad, Harriet de Wit
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 26, 2025
For those with schizophrenia, does cannabidiol make cannabis use safer?
Anya K Bershad
Biological Psychiatry
|
August 23, 2023
Psychedelic Microdosing: What Is It Good For?
Anya K Bershad
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
February 10, 2024
Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy
Yasmin Schmid, Anya K Bershad
Biological Psychiatry
|
July 20, 2019
Beyond Bootstraps: Pulling Children Up With Evidence-Based Interventions
Anya K Bershad, David A Ross
Schizophrenia Bulletin
|
June 26, 2023
Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia
Anya K Bershad, Harriet de Wit
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 9, 2019
MDMA enhances pleasantness of affective touch
Harriet de Wit, Anya K Bershad
Biological Psychiatry
|
September 14, 2024
Social Homeostasis and Psychoactive Drugs: What Can We Learn From Opioid and Amphetamine Drug Challenge Studies in Humans?
Anya K Bershad, Harriet de Wit
Journal of Psychopharmacology (Oxford, England)
|
May 29, 2016
Effects of d-amphetamine upon psychosocial stress responses
Emma Childs, Anya K Bershad, Harriet de Wit
Journal of Psychopharmacology (Oxford, England)
|
May 4, 2021
Challenges in translational research: MDMA in the laboratory versus therapeutic settings
Harriet de Wit, Anya K Bershad, Charles Grob
Psychoneuroendocrinology
|
September 1, 2017
Pharmacological challenge studies with acute psychosocial stress
Kathryne Van Hedger, Anya K Bershad, Harriet de Wit
Page
of 3